Stephen A. Sherwin, Director at BIOGEN INC. (BIIB), sold 17,520 shares at $150.02 ($2.6M) on 2025-03-07, disclosed to the SEC on 2025-03-10.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.02 | 8,760 | $1.3M | 50.0% |
| 2 | $150.02 | 8,760 | $1.3M | 50.0% |
| Total | $150.02 avg | 17,520 | $2.6M | 100% |
| Filing → |
| NBIX | SELL | 2024-05-30 | $5.3M | — | Filing → |
| NBIX | SELL | 2023-01-05 | $3.6M | — | Filing → |
| NBIX | SELL | 2022-01-26 | $1.1M | — | Filing → |